| INPP4B is an oncogenic regulator in human colon cancer ST Guo, MN Chi, RH Yang, XY Guo, LK Zan, CY Wang, YF Xi, L Jin, ... Oncogene 35 (23), 3049-3061, 2016 | 74 | 2016 |
| Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia-and Alzheimer’s-associated amyloid beta peptide JH Cater, JR Kumita, R Zeineddine Abdallah, G Zhao, ... Proceedings of the National Academy of Sciences 116 (13), 6101-6110, 2019 | 67 | 2019 |
| Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells M Chi, H Evans, J Gilchrist, J Mayhew, A Hoffman, EA Pearsall, ... Scientific reports 6 (1), 33132, 2016 | 61 | 2016 |
| Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3 F Lai, ST Guo, L Jin, CC Jiang, CY Wang, A Croft, MN Chi, HY Tseng, ... Cell death & disease 4 (6), e655-e655, 2013 | 60 | 2013 |
| Can hemp help? Low-THC cannabis and non-THC cannabinoids for the treatment of cancer F Afrin, M Chi, AL Eamens, RJ Duchatel, AM Douglas, J Schneider, ... Cancers 12 (4), 1033, 2020 | 58 | 2020 |
| INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas MN Chi, ST Guo, JS Wilmott, XY Guo, XG Yan, CY Wang, XY Liu, L Jin, ... Oncotarget 6 (37), 39891, 2015 | 56 | 2015 |
| Insulin induces drug resistance in melanoma through activation of the PI3K/Akt pathway M Chi, Y Ye, XD Zhang, J Chen Drug design, development and therapy, 255-262, 2014 | 50 | 2014 |
| Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy M Chi, J Chen, Y Ye, HY Tseng, F Lai, KH Tay, L Jin, ST Guo, CC Jiang, ... Current medicinal chemistry 21 (10), 1255-1267, 2014 | 44 | 2014 |
| Obesity and melanoma: exploring molecular links J Chen, M Chi, C Chen, XD Zhang Journal of cellular biochemistry 114 (9), 1955-1961, 2013 | 25 | 2013 |
| Involvement of vacuolar H+‐ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720 KH Tay, X Liu, M Chi, L Jin, CC Jiang, ST Guo, NM Verrills, HY Tseng, ... Pigment Cell & Melanoma Research 28 (2), 171-183, 2015 | 22 | 2015 |
| Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia MD Dun, A Mannan, CJ Rigby, S Butler, HD Toop, D Beck, P Connerty, ... Leukemia 34 (12), 3393-3397, 2020 | 18 | 2020 |
| FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice A Shrestha, M Chi, K Wagner, A Malik, J Korpik, A Drake, K Fulzele, ... Blood Advances 5 (9), 2385-2390, 2021 | 17 | 2021 |
| Oral administration of FT-4202, an allosteric activator of pyruvate kinase-R, has potent anti-sickling effects in a sickle cell anemia (SCA) mouse model, resulting in improved … A Shrestha, M Chi, K Wagner, A Drake, K Fulzele, S Guichard, P Malik Blood 136, 21-22, 2020 | 9 | 2020 |
| A novel role for brain and acute leukemia cytoplasmic (BAALC) in human breast cancer metastasis M Birgersson, M Chi, C Miller, JS Brzozowski, J Brown, L Schofield, ... Frontiers in oncology 11, 656120, 2021 | 4 | 2021 |
| The possible use of hypericin to overcome drug resistance in cancer treatment G Ni, M Chi, J Chen Chemico-Biological Interactions 190 (2), 188-189, 2011 | 2 | 2011 |
| CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease S Khanal, L Neidemire-Colley, KM Braunreiter, K Snyder, Y Gao, ... Blood 140 (Supplement 1), 10200-10201, 2022 | 1 | 2022 |
| Inositol polyphosphate 4-phosphatase II activates PI3K/SGK3 signaling to promote proliferation of human melanoma cells CC Jiang, MN Chi, ST Guo, JS Wilmott, XY Guo, XG Yan, CY Wang, ... Cancer Research 75 (15_Supplement), 4718-4718, 2015 | 1 | 2015 |
| CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model L Neidemire-Colley, S Khanal, KM Braunreiter, Y Gao, R Kumar, ... Blood Advances 8 (4), 947-958, 2024 | | 2024 |
| CRISPR/Cas9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease LM Neidemire-Colley, S Khanal, KM Braunreiter, KJ Snyder, Y Gao, ... The Journal of Immunology 210 (1_Supplement), 173.21-173.21, 2023 | | 2023 |
| Investigation into the in vitro, ex vivo and in vivo anti-acute myeloid leukaemia activity of cannabidiol (CBD) and low-delta-9-tetrahydrocannabinol (Delta 9-THC) containing … F Afrin, M Chi, A Mannan, A Woldu, R Duchatel, AM Douglas, H Murray, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 21-21, 2021 | | 2021 |
